Breaking News Instant updates and real-time market news.

HZN

Horizon Global

$8.00

0.06 (0.76%)

05:11
04/13/18
04/13
05:11
04/13/18
05:11

Horizon Global initiated with a Buy at B. Riley FBR

B. Riley FBR analyst Josh Nichols started Horizon Global with a Buy rating and $12.50 price target. The analyst says the stock is out of favor despite the company's leading market position and "significant" EBITDA growth.

HZN Horizon Global
$8.00

0.06 (0.76%)

01/29/18
BMOC
01/29/18
DOWNGRADE
BMOC
Market Perform
Horizon Global downgraded to Market Perform from Outperform at BMO Capital
01/30/18
BMOC
01/30/18
DOWNGRADE
Target $9
BMOC
Market Perform
Horizon Global cut to Market Perform at BMO Capital on operational uncertainty
As reported earlier, BMO Capital analyst Gerrick Johnson downgraded Horizon Global to Market Perform from Outperform and lowered his price target to $9 from $20. Johnson says that while he still sees "strong demand in key end markets", operation execution, rising input costs, and high debt levels are concerning. The analyst adds that the company may have "lost the faith of investors" after a 30% drop in the stock price following the guidance cut.
01/30/18
01/30/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AbbVie (ABBV) downgraded to Underperform from Market Perform by analyst Alex Arfaei, who said the risk/reward has "meaningfully changed" after the rise in the stock price, adding that the new focus on fundamentals beyond the benefits of tax reform suggests "significant price erosion in immunology driven by interchangeable biosimilar anti-TNFs, and lower effectiveness of the 'Rebate Trap' to block access to cheap biosimilars". 2. iRobot (IRBT) downgraded to Neutral from Buy at Sidoti by analyst Frank Camma, who cited valuation as shares approach his $98 price target. 3. Horizon Global (HZN) downgraded to Market Perform from Outperform at BMO Capital by analyst Gerrick Johnson, who said that while he still sees "strong demand in key end markets," operation execution, rising input costs, and high debt levels are concerning. The analyst added that the company may have "lost the faith of investors" after a 30% drop in the stock price following the guidance cut. 4. Yum! Brands (YUM) downgraded to Neutral from Buy at Nomura Instinet by analyst Mark Kalinowshi, who cited valuation and concerns a possible 2018 slowdown in U.S. same-store-sales. 5. Alaska Air (ALK) downgraded to Underweight from Neutral at JPMorgan by analyst Jamie Baker, who noted that the airline is the only name where he had to cut his 2019 estimates. He also believes the company "remains in the United crosshairs in San Francisco." The analyst also downgraded Southwest (LUV) to Neutral from Overweight, and said he believes better relative value exists elsewhere in the Airlines sector. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/07/18
BOFA
02/07/18
UPGRADE
Target $10
BOFA
Buy
Horizon Global upgraded to Buy from Underperform at BofA/Merrill
BofA/Merrill analyst Elizabeth L Suzuki upgraded Horizon Global two notches to Buy from Underperform saying the share sell-off has "washed out" the stock and maintained a $10 price target.

TODAY'S FREE FLY STORIES

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
10/23/18
10/23
15:16
10/23/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBPH

Theravance Biopharma

$28.10

-0.32 (-1.13%)

, JNJ

Johnson & Johnson

$139.12

0.44 (0.32%)

15:06
10/23/18
10/23
15:06
10/23/18
15:06
Recommendations
Theravance Biopharma, Johnson & Johnson analyst commentary  »

Piper says Theravance…

TBPH

Theravance Biopharma

$28.10

-0.32 (-1.13%)

JNJ

Johnson & Johnson

$139.12

0.44 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 28

    Oct

  • 13

    Nov

  • 27

    Nov

  • 18

    Dec

15:05
10/23/18
10/23
15:05
10/23/18
15:05
General news
More from Bostic and Kaplan: Bostic favors raising rates four times this year »

More from Bostic and…

RRC

Range Resources

$16.52

-0.18 (-1.08%)

15:04
10/23/18
10/23
15:04
10/23/18
15:04
Options
Range Resources options imply 8.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

15:01
10/23/18
10/23
15:01
10/23/18
15:01
Hot Stocks
NY DFS authorizes Coinbase Global to form Coinbase Custody Trust Company »

New York Financial…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$51.59

-0.05 (-0.10%)

15:01
10/23/18
10/23
15:01
10/23/18
15:01
Hot Stocks
Wells Fargo raises share repurchase authority by 350M shares »

The Wells Fargo board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

HLT

Hilton

$69.20

-0.97 (-1.38%)

15:00
10/23/18
10/23
15:00
10/23/18
15:00
Options
Hilton options see continued interest ahead of earnings »

Hilton options see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

15:00
10/23/18
10/23
15:00
10/23/18
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

TSLA

Tesla

$292.51

31.48 (12.06%)

14:55
10/23/18
10/23
14:55
10/23/18
14:55
Hot Stocks
Citron's Left says would be 'wrong' to be short Tesla ahead of Q3 report »

Citron Research's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

IBTX

Independent Bank

$57.55

1.08 (1.91%)

14:54
10/23/18
10/23
14:54
10/23/18
14:54
Recommendations
Independent Bank analyst commentary  »

Independent Bank price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 09

    Nov

HXL

Hexcel

14:52
10/23/18
10/23
14:52
10/23/18
14:52
Upgrade
Hexcel rating change  »

Hexcel upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CVE

Cenovus Energy

$8.53

-0.085 (-0.99%)

14:50
10/23/18
10/23
14:50
10/23/18
14:50
Options
Afternoon call buyer in Cenovus Energy »

Afternoon call buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:50
10/23/18
10/23
14:50
10/23/18
14:50
General news
Fed's Kaplan reiterated the FOMC should gradual reduce accommodation »

Fed's Kaplan…

TXN

Texas Instruments

$99.84

0.1 (0.10%)

14:49
10/23/18
10/23
14:49
10/23/18
14:49
Options
Texas Instruments options imply 7.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BIIB

Biogen

$319.27

3.6 (1.14%)

14:47
10/23/18
10/23
14:47
10/23/18
14:47
Recommendations
Biogen analyst commentary  »

Piper a buyer of Biogen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

TSLA

Tesla

$292.44

31.41 (12.03%)

14:44
10/23/18
10/23
14:44
10/23/18
14:44
Hot Stocks
Musk says Tesla will cut some interior configuration options for Model S, X »

Tesla CEO Elon Musk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

VNQ

Vanguard REIT Index Fund

$77.68

0.64 (0.83%)

14:40
10/23/18
10/23
14:40
10/23/18
14:40
Options
66K Vanguard Real Estate Fund Dec 76 - Jan 72 put spreads trade 71c »

66K Vanguard Real Estate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VEEV

Veeva

$88.99

-2.77 (-3.02%)

14:35
10/23/18
10/23
14:35
10/23/18
14:35
Options
Veeva put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:35
10/23/18
10/23
14:35
10/23/18
14:35
General news
Fed Board minutes showed showed most Banks supported the September 26 rate hike »

Fed Board minutes showed…

TSLA

Tesla

$292.00

30.97 (11.86%)

14:32
10/23/18
10/23
14:32
10/23/18
14:32
Recommendations
Tesla analyst commentary  »

Tesla's moved up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

TTWO

Take-Two

$118.82

-1.69 (-1.40%)

14:30
10/23/18
10/23
14:30
10/23/18
14:30
Periodicals
'Red Dead Redemption 2' development a difficult experience, Kotaku says »

Take-Two's Rockstar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

SELB

Selecta Biosciences

$9.25

-4.12 (-30.82%)

, HZNP

Horizon Pharma

$18.49

-0.76 (-3.95%)

14:29
10/23/18
10/23
14:29
10/23/18
14:29
Recommendations
Selecta Biosciences, Horizon Pharma analyst commentary  »

Selecta SEL-212 data…

SELB

Selecta Biosciences

$9.25

-4.12 (-30.82%)

HZNP

Horizon Pharma

$18.49

-0.76 (-3.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 07

    Nov

  • 27

    Nov

BCS

Barclays

$8.60

0.11 (1.30%)

14:20
10/23/18
10/23
14:20
10/23/18
14:20
Options
8-strike put buyers in Barclays Bank ahead of earnings »

8-strike put buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SELB

Selecta Biosciences

$8.93

-4.44 (-33.21%)

14:19
10/23/18
10/23
14:19
10/23/18
14:19
Recommendations
Selecta Biosciences analyst commentary  »

Selecta Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SLG

SL Green Realty

$92.15

0.36 (0.39%)

14:18
10/23/18
10/23
14:18
10/23/18
14:18
Downgrade
SL Green Realty rating change  »

SL Green Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.